Article Versions Notes

Lorentzen EU, Vollenberg R, Neddermeyer R, Schoefbaenker M, Hrincius ER, Ludwig S, Tepasse P-R, Kuehn JE. SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients. Vaccines. 2025; 13(6):595. https://doi.org/10.3390/vaccines13060595

Lorentzen, Eva Ulla, Richard Vollenberg, Rieke Neddermeyer, Michael Schoefbaenker, Eike R. Hrincius, Stephan Ludwig, Phil-Robin Tepasse, and Joachim Ewald Kuehn. 2025. "SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients" Vaccines 13, no. 6: 595. https://doi.org/10.3390/vaccines13060595

Lorentzen, E. U., Vollenberg, R., Neddermeyer, R., Schoefbaenker, M., Hrincius, E. R., Ludwig, S., Tepasse, P.-R., & Kuehn, J. E. (2025). SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients. Vaccines, 13(6), 595. https://doi.org/10.3390/vaccines13060595